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In a number of animal species, the growth-associated protein (GAP), GAP-43 (aka: F1,
neuromodulin, B-50, G50, pp46), has been implicated in the regulation of presynaptic
vesicular function and axonal growth and plasticity via its own biochemical properties
and interactions with a number of other presynaptic proteins. Changes in the expression
of GAP-43 mRNA or distribution of the protein coincide with axonal outgrowth as a
consequence of neuronal damage and presynaptic rearrangement that would occur
following instances of elevated patterned neural activity including memory formation and
development. While functional enhancement in GAP-43 mRNA and/or protein activity
has historically been hypothesized as a central mediator of axonal neuroplastic and
regenerative responses in the central nervous system, it does not appear to be the
crucial substrate sufficient for driving these responses. This review explores the historical
discovery of GAP-43 (and associated monikers), its transcriptional, post-transcriptional
and post-translational regulation and current understanding of protein interactions and
regulation with respect to its role in axonal function. While GAP-43 itself appears to have
moved from a pivotal to a supporting factor, there is no doubt that investigations into
its functions have provided a clearer understanding of the biochemical underpinnings of
axonal plasticity.
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GAP-43 HISTORICAL OVERVIEW
The growth-associated protein (GAP), GAP-43, has been known under various designations (see
below) over the span of 40+ years in the course of separate yet overlapping investigations into
phosphoproteins that contribute to plasticity and growth of the presynaptic terminal. Exploring
this history has revealed the basic properties of this growth- and plasticity-related protein that
set the foundation for work to determine whether this protein was a choke point for axonal
malleability during states of plasticity or a component of a larger presynaptic proteome. From this
historical perspective, it is clear that this presynaptic phosphoprotein of 43 kDa generated some
excitement as it rose to the forefront of other polypeptides that were also under investigation.
However, it also became clear that this protein functioned as a cog in a larger set of proteins
and kinases to coordinate changes in axonal structure and function during times of plasticity.
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Growth-Associated Polypeptides
In 1974, a 43 kDa polypeptide was one among seven polypeptides
noted to be present in the rabbit optic tract 8 days (but not earlier)
following intraocular injection of [35S] methionine suggesting a
slow transport rate of between 2mm/day and 4mm/day for these
proteins (Willard et al., 1974). This 43 kDa polypeptide showed
up again in the distal optic tract of both the guinea pig and
rabbit 8 days following intraocular injection and was considered
to be in the same group (Group IV based on axonal transport
velocities) as actin and two forms of myosin-like polypeptides
(Levine and Willard, 1980). The group IV polypeptides (bands
39, 43, S8, S29T, S13, S15 and S17 as noted in the article) were also
prominent in the optic nerve of the toad preparation 8 days after
injection (Skene and Willard, 1981b,d). This group contained at
least 13 protein bands that were similar in the rabbit and toad
and comprised the major fraction of labeled transported protein
associated with actin (Willard et al., 1979; Skene and Willard,
1981b,d). Polypeptide 43 was found to be labeled in a temporal
sequence similar to that of actin but disappeared more rapidly
than actin in the optic nerve and optic tract (Willard et al.,
1979). The authors suggested that the presence of polypeptide
43 in their sample may have been due to an interaction with
bound actin (Willard et al., 1979). While there were a number
of polypeptides associated with the actin-associated group IV
polypeptides, these reports appear to be the first that initiated
a series of experimental reports exploring the function of the
43 kDa polypeptide. However, this series of studies hinted that
a diverse group of proteins was involved in axonal plasticity and
it might be the sum of the functional properties of all the proteins,
rather than one, that coordinated axonal dynamics.
Skene and Willard (1981b) detected rapidly transported
polypeptides, referred to as GAPs of molecular weights of 24,
43 and 50 kDa, that showed a 20-fold increase in labeling
over baseline following optic nerve crush in the frog. They
showed that GAP-43, in particular, was transported in retinal
ganglion cell axons of neonatal animals with a rapid decline
during later stages of development highlighting a pattern of
high expression during development and reduced expression
during adulthood (Skene and Willard, 1981a). It was also
shown that the GAP-43 protein was elevated after axotomy of
the adult hypoglossal nerve, which regenerates, but was not
induced by nonregenerating optic nerve injury in the adult
(Skene and Willard, 1981a). In a third article by Skene and
Willard (1981c), they reported on additional characteristics of
three polypeptides that showed significantly elevated labeling
during the regeneration of toad optic nerves. The three growth-
associated polypeptides (GAP-24, GAP-43 and GAP50) showed
strong associations with the plasma membrane and were judged
to contain segments that extended away from the membrane
(Skene and Willard, 1981c). GAP-50 (half-life = ∼1 day) and
GAP-43 (half-life = ∼2–3 days) appeared to be transported
preferentially to axon tips while GAP-24 (half-life = ∼4–6 h)
was distributed more uniformly along the axons. The authors
offered the ‘‘GAP hypothesis’’ whereby these proteins would
mediate functions critical for axon growth such that increased
presence of any of these GAPs in a few neurons would be
reflective of those neurons undergoing some form of axon
growth (Skene and Willard, 1981a,b). They further suggested
that regeneration would mimic an earlier development period
of the neuron and that a number of GAPs (including GAP-43)
would be involved in axon elongation (Skene and Willard,
1981a). Because GAP-43 showed a high concentration in the
terminal portion of the axon, it was hypothesized to serve a
critical link between the internal environment of the growing
axonal tip and the intercellular environment (Skene andWillard,
1981c). However, once again, while GAP-43 was highlighted, the
evidence suggested that it may be one of several proteins that
subserves axonal plasticity.
The Synaptic Phosphoprotein B-50
While studying the effects of adrenocorticotropic hormone
(ACTH) on the phosphorylation of synaptic plasma membrane
proteins in vitro, Zwiers et al. (1976) found that phosphorylation
of a protein located at band 5 (48 kDa; among additional
proteins located at bands 1 and 6–10) was insensitive to cAMP
while bands 6–10 showed decreased phosphorylation in the
presence of ACTH. In a methodological article examining
the phosphorylation of separated synaptic plasma membrane
proteins, the use of densitometric scanning with higher
resolution resulted in the identification of more phosphoprotein
peaks and a renumbering of protein bands (Wiegant et al., 1978).
In this report, the scans were divided into four areas (A–D)
with the main peaks numbered in tens. Therefore, the peak
previously designated ‘‘5’’ (Zwiers et al., 1976) was designated
B-50 (Wiegant et al., 1978). The phosphorylation of B-50 was
shown to be inhibited by ACTH via an interaction with protein
kinase activity in proximity to the membrane (Zwiers et al., 1978,
1979). A number of studies followed (see, Zwiers et al., 1980a,b)
that examined the upstream kinase/phosphorylation aspects of
B-50 as well its downstream effects on the phosphorylation of
lipid membranes (Jolles et al., 1980). Protein kinase C (PKC) was
shown to phosphorylate B-50 (Aloyo et al., 1982a,b) in a calcium-
dependent fashion (Aloyo et al., 1983). Several articles examining
the localization of synaptic membrane phosphoproteins found
B-50 to be localized exclusively to nervous tissue (as opposed
to a variety of peripheral organs; (Kristjansson et al., 1982) and
within nervous tissue, to low density presynaptic membranes
(Oestreicher et al., 1981; Sorensen et al., 1981; Gispen et al.,
1985). These fundamental properties of B-50 were very similar
to those described for GAP-43 (as above) but also showed
that B-50 was not alone in its existence in the presynaptic
compartment.
CyclicAMP-Independent
Phosphoprotein F1
In 1974, Ehrlich and Routtenberg (1974) reported on the
properties of three phosphoproteins from the cerebral cortex
that they termed D, E and F. B and F showed the highest
level of endogenous phosphorylation but the phosphorylation
status was not changed by addition of cAMP (Ehrlich and
Routtenberg, 1974). Because Ehrlich and Routtenberg (1974)
used the crude synaptosome preparation, their samples would
have included the necessary enzymes and proteins (such as
protein kinases) required for the actions of cAMP to facilitate
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the phosphorylation of a wide range of substrates (Bai and
Witzmann, 2007; Kamat et al., 2014). In a follow-up study,
protein component F (estimated to be 47 kDa) was shown
to be the least sensitive to the effects of cAMP but attained
the highest level of phosphorylation in the absence of cAMP
(Routtenberg and Ehrlich, 1975) indicative of ‘‘some unique
function for protein F’’ (p. 426; Routtenberg and Ehrlich, 1975).
Modification of the phosphorylation status of band F and
a composite band H-1 (estimated molecular weights 47 kDa
and 10–18 kDa, respectively) were shown to be significantly
increased 24 h after footshock and/or learning to escape from
a footshock but minimally stimulated by the addition of cAMP
(Ehrlich et al., 1977). The authors suggested the involvement
of these proteins in some aspect of memory because the
phosphorylation of F and H-1 was greater in the animals that had
escaped footshock than in animals that experienced inescapable
footshock (Ehrlich et al., 1977). In a similar, follow-up study,
rats that were shocked and rats that were trained to escape
footshock showed an elevation in phosphorylation activity of
protein bands F1 (41 kDa) and F2 (47 kDa) from the frontal
cortex (Routtenberg and Benson, 1980). While band F2 was
the only protein to show significantly elevated shock-associated
elevation in phosphorylation status, F1 showed the greatest
variability leading the authors to suggest that the variability
may be related to not only procedural aspects but also the
in vivo state of the enzymes at the time of tissue assessment
(Routtenberg and Benson, 1980). While these experiments
showed a tight relationship between protein F1 (aka, GAP-43)
its phosphorylation status and potential memory function, there
was no direct evidence for its role in axonal plasticity bridging
these functions.
In a report examining other factors that might influence the
in vivo phosphorylation state of protein F1, handling was shown
to significantly reduce F1 phosphorylation in the hippocampus
compared to non-handled rats (Cain and Routtenberg, 1983).
While this finding by itself is of interest, the introduction section
of the article makes reference to the likelihood that protein F1 is
the same as B-50. The Routtenberg lab continued to characterize
their protein F1 with respect to axonal plasticity (references
below) and Gispen et al. (1986) published a report to sanctify the
similarity between protein F1 and B-50. In the discussion of this
article, the authors described how protein F1/B-50 shared many
characteristics with GAP-43, GAP-48 and pp46.
Growth-Associated Protein (GAP)-43,
GAP-48, Protein 4, B-50, F-I, y5 and pp46
In a fourth line of research, an optic nerve crush model in fish
was used to examine changes in protein synthesis in retinal
ganglion cells during various stages of axonal regeneration
(Benowitz et al., 1981). Eight days after optic nerve crush,
the strongest signals were noted for proteins with molecular
weights of 24–27, 44 and 210 kDa (Benowitz et al., 1981).
The proteins in the range of 44–49 kDa were shown to
not only increase during the early stages of regeneration but
also increase independently from postsynaptic signals arising
from the tectum (Benowitz and Lewis, 1983; Yoon et al.,
1986). These proteins (44–49 kDa) were present in both the
membrane-bound and soluble fractions of material transported
from the retinal ganglion cells to the nerve terminals in the
tectum. During regeneration, their labeling increased up to
100-fold reflecting new protein synthesis and an increase in
total amount of protein present in the sample (Benowitz and
Lewis, 1983; Benowitz et al., 1983). Following up on this work,
an acidic, 48 kDa, membrane-bound protein (GAP-48) showed
a 50- to 100-fold increase in retinal ganglion cells undergoing
regeneration (Perrone-Bizzozero and Benowitz, 1987). Once
again, rather than only one protein being the sole factor
in axonal regeneration, it seemed rather that a number of
proteins worked together to coordinate appropriate regenerative
responses.
The discussion of this article appears to be one of the first
to compare GAP-48 and B-50 concluding that these proteins
are likely homologous (Perrone-Bizzozero and Benowitz, 1987).
The authors also described that B-50 was identical to GAP-43
(verified by Jacobson et al., 1986) and the same protein
designated as pp46 (Perrone-Bizzozero and Benowitz, 1987).
A link was also described for B-50 and F1 suggesting that
these proteins (GAP-48, GAP-43, B-50, F1, pp46) performed the
same function in playing a role in the initial development of
neural relationships and subsequent modulation as would occur
during regeneration and long-term potentiation (LTP; Perrone-
Bizzozero and Benowitz, 1987; Moya et al., 1988). The variations
in molecular weights of these various proteins was likely in
large part due to technical aspects of the assays (Benowitz et al.,
1987) and the likelihood that GAP-43/ B-50 protein existed as
a complex with PKC and phosphatidylinositol phosphate (PI3)-
kinase (Zwiers et al., 1980b; Jacobson et al., 1986; Nguyen et al.,
2009).
Neuromodulin
In 1983, Andreasen et al. (1983) characterized a protein they
termed P-57 that showed a strong affinity for calmodulin
(CaM) during conditions of low Ca2+ binding but CaM
dissociated from P-57 during conditions of high Ca2+ presence.
They proposed that P-57 may function to increase CaM
concentrations near the membrane and release it with elevations
in intracellular Ca2+ concentrations (Andreasen et al., 1983).
P-57 was found to be the most abundant CaM-binding protein
specifically located in the brain, spinal cord and retina but
no other tissues (Cimler et al., 1985). Within these neural
tissues, it was found in both membrane (white matter) and
soluble (cell body) fractions (Cimler et al., 1985). P-57 was
estimated to have a molecular weight of 25.7 kDa and the
P-57-CaM complex was estimated to have a molecular weight
of 45.6 kDa (Masure et al., 1986). The Ca2+-dependent
PKC phosphorylated P-57 at a serine residue but P-57 was
not phosphorylated by the cAMP-dependent protein kinase
(Alexander et al., 1987). An interesting relationship between
the binding of CaM and PKC to P-57 was then determined
such that CaM decreased the rate of P-57 phosphorylation
by PKC and PKC phosphorylation prevented P-57 binding to
CaM suggesting CaM may be liberated from P-57 via rises in
intracellular Ca2+-dependent PKC phosphorylation (Alexander
et al., 1987). The P-57 sequence contained a hydrophilic amino
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acid composition but lacked a hydrophobic segment that would
indicate an interaction with the membrane (Wakim et al., 1987).
The neurospecific CaM-binding protein was then renamed
neuromodulin (Alexander et al., 1988) and was determined
to be similar to p-57, GAP-43, B-50 and F1 (Baudier et al.,
1989).
Summary
Seemingly, five independent lines of research came to
complementary and overlapping conclusions on the fundamental
properties of an axonal-associated membrane-bound protein
related to axonal plasticity. The varied molecular weights
reported for the different protein terminologies were noted by
Benowitz et al. (1987) who discussed technical aspects such as
gel composition or the presence or absence of detergent that
might contribute to the differential weights. Other contributing
factors to the weight differences were suggested to be the status
of the protein when run on the gels such as phosphorylated or
bound by CaM, or whether it was bound with other membrane
proteins. Nevertheless, converging lines of evidence indicated
that these varied observations were of a protein with the same
function. There were also independent observations from
each line of work that stimulated in-depth investigations in
to the molecular and biochemical aspects of this protein and
its potential contribution to axonal outgrowth. However, it
must be kept in mind that through these five foundational
lines of research, there were a number of other proteins that
showed similar properties with respect to axonal outgrowth
and it might be concluded that no one protein was a pivotal
factor but that all proteins played a supporting role in axonal
plasticity—including GAP-43. While the author of this review
concludes that the transcriptional, post-transcription and
post-translational regulation of numerous proteins coordinates
axonal plasticity, the work that explored the contribution
of GAP-43 to axonal outgrowth has been instrumental in
elucidating basic mechanisms of axonal growth and function.
GAP-43 AND PRESYNAPTIC PLASTICITY
Since those reports, interest in GAP-43 (the nomenclature for
this protein used in the current review) rose sharply peaking at
134 PubMed reports in 1995 but showing a decreasing trend over
the past 20 years (lowest in 2016 at 65 publications). It appears
that this protein was initially hailed as playing a pivotal role in
axonal outgrowth but has since become a contributing factor as
part of a larger group of axonal growth-permissive proteins. The
study of GAP-43 has revealed a tight relationship between its
expression and axonal structural plasticity during development,
a rise in its expression levels following axonal injury during
the regeneration phase and an association with input-dependent
neuroplastic processes, such as LTP and memory formation,
in conjunction with reorganization of axonal terminal fields
(Denny, 2006). The functional attributes of GAP-43 can
be ascribed to the transcriptional and post-transcriptional
regulation of the mRNA and the protein-kinase C-dependent
post-translational modification (phosphorylation) and protein
localization at the biochemical level. Many growth permissive
events in the central nervous system lead to elevations in GAP-43
so, while it may have moved from a pivotal role to a supporting
role, it is no doubt an important node in the protein network
involved in axonal function. A review of the transcriptional
and translational aspects of GAP-43 as they pertain to the
moderation of neuroplastic events in the central nervous system
will be examined in relation to the function of this protein as
an important node in axonal outgrowth during development and
regeneration following injury.
GAP-43 GENE CHARACTERISTICS
Gene and Transcriptional Regulation
Expression of GAP-43 mRNA is restricted to the nervous system,
and in particular, axons, where levels increase during periods
of neurite outgrowth (Karns et al., 1987). Developmental and
regeneration-associated changes in GAP-43 synthesis appear to
be mediated via transcription of the same, single gene (Basi
et al., 1987). The human and rat GAP-43 genes are thought
to be expressed in similar ways due to the existence of two
similar transcripts, a high amount of overlap between the
sequences, and promoter activities (Nedivi et al., 1992; Ortoft
et al., 1993; de Groen et al., 1995; Udvadia et al., 2001).
The human GAP-43 gene has been localized to chromosome
3 while the mouse GAP-43 gene is localized to chromosome
16 (Kosik et al., 1988) and the rat GAP-43 gene localized to
chromosome 11 (Figure 1). On the rat GAP-43 gene, there
are proximal (E1 and E2) and distal (E3 to E7) clusters of
E-boxes (Chiaramello et al., 1996). The regulation of GAP-43
expression occurs via a basic helix-loop-helix mechanism acting
on the E1 E-box positioned in active P2 promoter that is
neuronally restricted. The E1 E-box is the only E-box that
is conserved between the rat and human GAP-43 promoter
regions with respect to core sequence, flanking sequence, and
position (Chiaramello et al., 1996). The GAP-43 gene contains
two promoters: P1 consists of promoter elements such as TATA
and CCAAT boxes (Nedivi et al., 1992; Ortoft et al., 1993) while
P2 does not encompass either of these elements (Eggen et al.,
1994; Weber and Skene, 1997). Within the GAP-43 gene is a
repressive element (also found on SNAP-25 and nNOS genes
aptly named ‘‘SNOG’’) found downstream of the TATA region
that contributes to the neuron specificity of gene expression by
inhibiting transcription in a variety of non-neuronal cells and
tissues (Weber and Skene, 1997, 1998). The majority of GAP-43
mRNA is derived from the P2 promoter in both P19-EC cells
and 8-day old rat brain (Eggen et al., 1994) suggesting that the
P2 promoter may play a more prominent role in regulation of
outgrowth.
The GAP-43 gene includes three exons in both the rat
(Grabczyk et al., 1990) and human (Nielander et al., 1993).
The first exon encodes the N-terminal 10 amino acids of
the membrane-targeting domain; the second exon encodes the
CaM-binding domain and PKC phosphorylation site; exon 2 in
humans includes a 10 amino acid residue insert not found
in rodents (Grabczyk et al., 1990). These gene characteristics
confirm the earlier studies showing the CaM and PKC
post-translational modification domains.
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FIGURE 1 | Location of growth-associated protein (GAP)-43 gene on
chromosomes of different species. (A) Human chromosome 3 showing
GAP-43 gene at locus 3q13.31; (B) Mouse chromosome 16 showing GAP-43
at 16 B4; 16 28.37 cM; (C) Rat chromosome 11 showing GAP-43 gene at
11q21. Images adapted from Yates et al. (2016). Red line indicates position of
GAP-43 gene for each species and chromosome.
Post-Transcriptional Regulation
Modulation of the degradation rate of GAP-43 mRNA appears
to be a main factor in the control of mRNA levels during
neurite outgrowth (Perrone-Bizzozero et al., 1991). Nerve growth
factor (NGF) and phorbol ester (TPA) have been shown to
selectively stabilize GAP-43 mRNA in PC12 cells (Perrone-
Bizzozero et al., 1993). PKC activity appears to regulate GAP-43
mRNA in a translation-independent mechanism as inhibition
of PKC, but not treatment with cycloheximide, can prevent
NGF- and TPA-induced stabilization of GAP-43 (Perrone-
Bizzozero et al., 1993). The ELAV-like protein 4 (HuD; Szabo
et al., 1991; Sanna et al., 2014b), a neuronal RNA-binding
protein (Mobarak et al., 2000), appears to be a main stabilizing
agent for GAP-43 mRNA. Events associated with elevated
HuD expression include times of neural development, during
the course of nerve regeneration, and episodes of stimulus-
dependent modification such as memory functions (Deschênes-
Furry et al., 2007). Based on this, HuD has been hypothesized
to be important for prolonging gene stability and, as such,
would be instrumental in sustaining elevated levels of mRNA
species associated with axonal outgrowth including GAP-43
mRNA (Perrone-Bizzozero and Bolognani, 2002). Experimental
evidence has shown prolonged stability of GAP-43 mRNA in
neural tissue from mice expressing elevated levels of HuD
via transgenic means compared to non-transgenic littermates
supporting the contention that HuD can positively affect GAP-43
mRNA stability (Bolognani et al., 2006). As well, transgenic
overexpression of HuD was associated with an increase in
GAP-43 mRNA expression in granule cells of the hippocampal
dentate gyrus, neurons in the lateral amygdala and layer V
neurons of the cortex (Bolognani et al., 2006). Inhibition of PKC
prevents HuD and GAP-43 overexpression and decreasing levels
of PKCγ and HuD were associated with GAP-43 reductions
(Sanna et al., 2014a). The HUD-dependent stabilization of
GAP-43 mRNA or other mRNAs involved in axonal outgrowth
could prove to be key elements in enhancing axonal growth
and regeneration. In essence the continued work in identifying
key transcriptional and post-transcriptional regulators of a larger
set of regeneration-associated genes, rather than individual
genes like GAP-43, lends support to the conclusion that
a number of axonal proteins function together to mediate
plasticity.
GAP-43 PROTEIN
Translational and Post-Translational
Characteristics
In humans, GAP-43 is 238 amino acids, while in the mouse,
it is 227; in the rat, 226 and in the frog, 214 amino acids
(see Figure 2). The hydrophilic protein (Chan et al., 1986) is
encoded by a 1.5 kb brain-specific, developmentally-regulated
mRNA (Rosenthal et al., 1987) and lacks a membrane-spanning
domain and contains no sites for glycosylation (Basi et al., 1987).
Analysis has revealed a short hydrophobic amino acid sequence
segment which functions to anchor the GAP-43 protein on the
cytoplasmic side of the presynaptic plasmamembrane (Basi et al.,
1987; Gorgels et al., 1989). Localization of GAP-43 protein to
the inner surface of the plasma membrane of growing axons,
including growth cones, is based on palmitoylation of Cys3 and
Cys4 (Strittmatter et al., 1994; Kong et al., 2013; Tuodziecka et al.,
2013). Primary palmitoylation takes place at the endoplasmic
reticulum-Golgi intermediate compartment (McLaughlin and
Denny, 1999). A reduction in the palmitoylation of GAP-43
and other growth-related proteins is sufficient to stop advancing
axons during critical remodeling periods and only at the close
of these remodeling periods, does the availability of these
proteins (including GAP-43) decline (Patterson and Skene,
1999) suggesting other post-translational modifications take
over to stabilize or fine tune synaptic terminals. In this case,
palmitoylation serves to post-translationally modify GAP-43 for
transport to the membrane then local phosphorylation follows
to regulate protein mobility and plasma membrane targeting of
GAP-43 (Gauthier-Kemper et al., 2014).
Phosphorylation of GAP-43 importantly contributes to
the biochemical and physiological activities of the protein
with Ser41 being the singular target of PKC-regulated
phosphorylation, (Meiri et al., 1988; Coggins and Zwiers,
1989; Yi et al., 2011) specifically, PKCbeta (Rosenthal et al., 1987;
Sheu et al., 1990b). With low Ca2+ levels in the presynaptic
terminal, CaM shows a high affinity for GAP-43 and when
Ca2+ levels rise, as during high plasticity events, CaM is
released (Neve et al., 1998). If the Ser41 site is transformed
from serine to aspartate with the outcome of mimicking
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FIGURE 2 | Protein binding domains of GAP-43 for various species. (A) Human, (B) mouse, (C) rat and (D) frog. Sequences as found at
http://www.ebi.ac.uk/interpro/protein/P06837/similar-proteins. Additional details comparing individual amino acid sequences for human, mouse and rat can be
found at http://www.phosphosite.org/proteinAction?id=2142&showAllSites=true.
constitutive phosphorylation, binding of CaM to GAP-43 is
absent (Chao et al., 1996). CaM binding can entirely prevent
PKC-induced phosphorylation of GAP-43 so serves to quell
the activity of GAP-43 during periods of low activity in
neurons (Chan et al., 1986; Kumar et al., 2013). If Ser41 is
mutated from serine to alanine (S41A), phosphorylation is
prevented and there is a discernible reduction in presynaptic
branching and growth and, indeed, only half of brain/spinal
neurons expressing S41A successfully initiate axonal outgrowth
(vs. nearly 100% for wild type GAP-43; Leu et al., 2010). This
shows the importance of the amino acid sequence that flanks
the Ser41 phosphorylation site in the promotion of outgrowth
and may be due, in part, to a liberation of CaM and interactions
with PIP2 (see below). The results of this report also indicated
that the PKC-GAP-43 pathway contributes to an F-actin based
process in the stabilization of new synapses and initiation of
new terminal branches (Leu et al., 2010). Therefore, changes
in the phosphorylation status of GAP-43 is a critical factor in
its contribution to axonal outgrowth. Equally important is the
liberation of CaM upon phosphorylation, which may be a pivotal
factor in mediating axonal outgrowth via interactions with the
presynaptic proteome. In this respect, GAP-43 would serve to
liberate the pivotal factor (CaM) thereby serving a permissive
role in axonal outgrowth mechanisms.
In the absence of Ca2+, arachidonic acid (AA) imparts
a marginal effect on GAP-43 phosphorylation (Schaechter
and Benowitz, 1993). AA, a retrograde stabilizing factor, is
released by cytoplasmic phospholipase A2 (cPLA2) after Ca2+
entry through activated post-synaptic N-methyl-D-aspartate
receptors (NMDARs) and can activate presynaptic PKC to
phosphorylate various substrates such as GAP-43 to regulate
cytoskeletal dynamics (Leu and Schmidt, 2008; Leu et al., 2010)
directly or via the release of CaM. Because of these NMDAr-
mediated retrograde responses, NMDAr’s have been functionally
associated with the GAP-43 protein even though NMDAr’s are
postsynaptically located and GAP-43 has a presynaptic location.
When Ca2+ levels rise to those that mimic levels in the nerve
terminal during synaptic activity, AA works synergistically with
Ca2+ to increase the sensitivity of GAP-43 phosphorylation
and bump up the maximal phosphorylation level by 50%
(Schaechter and Benowitz, 1993). The augmenting endpoint
of the synergistic actions of AA and Ca2+ is mediated by
PKC-induced phosphorylation (Schaechter and Benowitz, 1993).
In the optic nerve preparation, AA induces NCAM promotion of
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axon outgrowth by activating PKC-induced phosphorylation of
presynaptic GAP-43 and ultimately, the stabilization of F-actin
(Schmidt et al., 2004).
Protein Interactions
An important consideration in determining that GAP-43 is a
supporting factor in axonal outgrowth and function is through
the examination of protein interactions (see Holahan, 2015 for
summary diagrams). When GAP-43 is phosphorylated by PKC
following rises in intracellular Ca2+, it interacts with other
proteins to facilitate axonal elongation and vesicular cycling. One
functional outcome of PKC-induced phosphorylation of GAP-43
during activity-dependent increases in presynaptic Ca2+ levels
is the modulation of synaptic vesicle recycling (Cousin, 2000).
The facilitation of exo- and endocytotic processes likely occurs
through interactions with synaptophysin (Verkade et al., 1996;
Hou andDahlström, 2000), SNAP-25 (Goutan et al., 1999; Rekart
and Routtenberg, 2010) and rabaptin-5 (involved in membrane
fusion and membrane trafficking of recycled endosomes; Neve
et al., 1998; Chia et al., 2013). In its service to vesicle recycling,
GAP-43 augments extracellular signals through interactions
with the GTP-binding protein, Go, enhancing the sensitivity
of Go and altering the predilection for neuronal outgrowth
(Strittmatter et al., 1991, 1993, 1994). A second outcome of
PKC-induced phosphorylation of GAP-43 is the liberation of
CaM, which can then carry out its own independent functions
(not reviewed in detail here but for reviews, see McCue et al.,
2010; Naz et al., 2016). With the liberation of CaM from
phosphorylated GAP-43, it interacts with CaMKII resulting in
the phosphorylation of a number of substrates including cofilin
by LIM kinases, which result in neurite outgrowth (Arber et al.,
1998; Heng and Koh, 2010).
GAP-43 LOCALIZATION
Cellular Compartmentalization
The neuron-specificity of GAP-43 is highlighted with its high
density in presynaptic terminals in both the peripheral and
central nervous systems. In neuroglial cells, GAP-43 shows a
plasma membrane localization in neonatal rat cortical astrocytes
(Vitkovi c´ et al., 1988; Vitkovi c´ and Mersel, 1989; da Cunha
et al., 1991) as well as oligodendrocytes and type 2 astrocytes
(Deloulme et al., 1990). In neuronal cells, GAP-43 is distributed
throughout all neural compartments but shows the highest
density in axon terminals including growth cones (Donnelly
et al., 2013; Yoo et al., 2013). GAP-43 is largely absent from
dendrites and myelinated axons as shown by a lack of double
labeling with microtubule-associated protein 2 (MAP-2) and the
large neurofilament proteins (Ramakers et al., 1992). Double-
immunohistochemical labeling in cultured hippocampal neurons
shows that GAP-43 colocalizes with the axonal marker Tau with
the strongest signal at axonal puncta of developing neurons
(Morita and Miyata, 2013). During the period of neurite
extension in cultured neurons, the soma shows reduced GAP-43
staining and the growing tips of the axons (i.e., growth cones)
show increased, punctate GAP-43 staining (Meiri et al., 1988).
The growth-cone localized GAP-43 is associated with the inner
membrane surface as shown by positive immunostaining after
permeabilization of the membrane (Meiri et al., 1988). With
respect to its localization to neurons, there was an absence of
GAP-43 labeling in Schwann cells and fibroblasts (Meiri et al.,
1988). These data point to a strong association between the
presence of GAP-43 and outgrowth of axons.
Due to its cellular localization, GAP-43 more than likely
contributes to axon terminal structural reorganization. In
this respect, GAP-43 has been shown to promote F-actin
accumulation as occurs following stimulus-induced nerve
sprouting at the neuromuscular junction (Frey et al., 2000).
During axonal structural modification, GAP-43 accumulates at
subplasmalemmal rafts on the inner membrane where it adjusts
F-actin accumulation via interactions with PI(4,5)P2 (Laux et al.,
2000). Down-regulation of GAP-43 function with an in vivo
lentiviral-mediated gene silencing technique resulted in the
degeneration of climbing fibers in the olivo-cerebellar system
as assessed with a decrease in length, branching and number
of synaptic boutons (Grasselli et al., 2011) showing a causal
relationship between GAP-43 levels in mediating this outgrowth.
Neuroanatomical Localization
GAP-43 is widely expressed in the central nervous system
during the perinatal period with subsequent reduced levels as
maturation progresses. In the mature central nervous system,
GAP-43 levels remain high in structures likely to undergo
input-dependent plasticity including the cerebellum (granule
cells (Casoli et al., 2001) but not Purkinje cells (Meberg and
Routtenberg, 1991)), neocortex, entorhinal cortex (Kruger et al.,
1992), hippocampus, olfactory bulb (McGuire et al., 1988; De
la Monte et al., 1989) and retinal cells (Freeman et al., 2011).
Significant levels of GAP-43 are also observed in adult-born
olfactory sensory neurons (Schwob et al., 1992). The idea
that GAP-43 may be of critical importance to growing axonal
terminals is supported by reports showing the localization of
GAP-43 expression in olfactory sensory neurons (Verhaagen
et al., 1989; Holtmaat et al., 1999), which are generated
throughout life. This finding allows a dissociation of axonal
development from effects on axonal outgrowth and suggests
an important contribution of GAP-43 to axonal growth no
matter when or where it is expressed. Layer I neurons of the
cortex and CA1 pyramidal cells of the hippocampus (Casoli
et al., 2003) but not hippocampal granule cells (Meberg and
Routtenberg, 1991; McNamara and Lenox, 1997) show dense
GAP-43 labeling. Pronounced labeling of GAP-43 has also been
found in a variety of adult subcortical structures such as the
caudate-putamen, olfactory tubercle (Ramakers et al., 1992),
nucleus accumbens, bed nucleus of the stria terminalis, amygdala
and medial preoptic area of the hypothalamus (Benowitz et al.,
1988). There is also some specificity of GAP-43 labeling overlap
with specific neurotransmitter systems such as those in the
substantia nigra pars compacta (dopamine), the locus coeruleus
(norepinephrine), and dorsal raphe (serotonin; Bendotti et al.,
1991; Meberg and Routtenberg, 1991; Kruger et al., 1993; Denny,
2006). The medial septum, nucleus basalis magnocellularis and
the vertical limb of the diagonal band express intermediate
GAP-43 levels, while the horizontal limb of the diagonal band
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and the substantia innominata express higher levels (McKinney
and Kent, 1994).
Within the spinal cord and brainstem, unmyelinated or
moderately myelinated areas, such as the substantia gelatinosa
and the nucleus of the solitary tract, express high levels of
GAP-43 (Kapfhammer and Schwab, 1994). GAP-43 staining
is detected in small unmyelinated axons (0.12–0.15 microns
diameter) and small (0.35 microns) axon terminals comprised
of round vesicles that form asymmetric synapses with thin
spines (DiFiglia et al., 1990). The localization of GAP-43 in
these small myelinated and unmyelinated fibers is found in
terminals that make single axodendritic or axosomatic synapses
(Curtis et al., 1993). Within motor neurons of the brainstem
and spinal cord, GAP-43 is present at all vertebral levels
with higher concentrations in cervical and thoracic regions
(Curtis et al., 1993; Berg et al., 2012; Gordon and Tetzlaff,
2015).
INVOLVEMENT IN DEVELOPMENTAL
OUTGROWTH OF AXONS
GAP-43 is noted to be involved in developmental neurite
outgrowth through the amplification of pathfinding signals
from the growth cone (Strittmatter et al., 1995). In cultured
neurons, GAP-43 labeling was clustered in growth cones 6 days
after plating and after 10 days, cell body labeling was absent
while at 20 days, the growth cone labeling was minimized
(Burry et al., 1991). Transgenic expression of GAP-43 in
mature olfactory sensory neurons, where GAP-43 is strongly
expressed in immature olfactory sensory neurons, produced
numerous olfactory axons with enlarged endings (Holtmaat
et al., 1995). This effect demonstrates that reintroduction of
a developmentally-regulated gene in neurons that no longer
express this gene can recapitulate a development axonal growth
process (Holtmaat et al., 1995). Developmentally-regulated
expression of GAP-43 and associated axonal growth has
been hypothesized to be controlled by activity-independent
transcriptional processes and input-dependent, NMDA-receptor
mediated posttranslational mechanisms (Cantallops and
Routtenberg, 1999).
Numerous factors interact with GAP-43 during neurite
outgrowth lending to the contention that GAP-43 may play a
supporting role in the orchestration of axonal outgrowth. A
marked increase in GAP-43 levels occurs in conjunction with the
induction of a neuronal phenotype in PC12 pheochromocytoma
cells by NGF (Irwin et al., 2002). Three hours after NGF
exposure, GAP-43 levels rise and reach maximal levels 24 h
after NGF application (Costello et al., 1990). In addition,
NGF-induced responses in PC12 cells can be enhanced
with upregulation of GAP-43 transfection, suggesting that
NGF interacts with presynaptic GAP-43 to modulate neurite
outgrowth (Neve et al., 1991). In cerebellar granule cells,
NCAM-mediated fibroblast growth factor (FGF) activation leads
to increased phosphorylation of GAP-43 and neurite outgrowth
and, importantly, neither NCAM nor FGF stimulated neurite
outgrowth when the GAP-43 gene was knocked-out (Meiri et al.,
1998).
During the early phases of development, newly formed
synapses show reduced levels of palmitoylated GAP-43
(Patterson and Skene, 1999) which may indicate a signal to
stop advancing axons, suggesting a developmental switch
for GAP-43 palmitoylation that is essential to disengage the
molecular apparatus for axon extension (Patterson and Skene,
1999). Using a culture system, the morphological relationship
between dorsal root ganglion (DRG) explants and dissociated
skeletal muscle (SKM) cells was investigated to determine the
influences on neurite growth and neuronal migration (Zhang
and Li, 2013). The number of migrating neurons and the
percentage of neurofilament (NF-200)- and GAP-43-positive
neurons and their associated mRNAs increased significantly
in neuromuscular cocultures (with SKM) compared to DRG
explants alone suggesting target SKM cells promote neurite
outgrowth and neuronal migration of DRG explants (Zhang and
Li, 2013).
GAP-43 expression and functional outcomes during
development appear to be brain region-dependent. In
cerebellar granule cells, GAP-43 mRNA expression functions in
differentiation and migration of neurons while in parallel and
climbing fibers, GAP-43 contributes to axonal outgrowth and
synaptogenesis (Console-Bram et al., 1996). In the cerebellum,
GAP-43 mRNA expression increases from birth to postnatal
day seven (PND 7) then declines during the ensuing sculpting
and maturation processes (Console-Bram et al., 1996). By
PND21, GAP-43 mRNA expression localizes to the internal
granule layer and inferior olivary nuclei with little hybridization
signal in deep cerebellar nuclei and absent expression in the
molecular layer as seen in the adult (Console-Bram et al., 1996).
In the optic nerve and optic fiber layer of the retina, GAP-43
staining was high at birth (PND0) and was absent between
PND8 and PND16 (Kapfhammer et al., 1994). In auditory
brainstem neurons, GAP-43 protein distribution is unmistakable
in the cochlear nuclear complex subdivisions and the superior
olivary complex at birth (PND0; Horváth et al., 1997). From
PND8 to PND12, GAP-43 staining in these areas becomes
punctate indicative of presynaptic ending formation. By PND16,
the auditory brainstem nuclei are mostly devoid of GAP-43
staining with the exception of the presynaptic terminal puncta
(Horváth et al., 1997). In cat primary visual cortex (VI), GAP-43
phosphorylation was elevated approximately 10-fold during
the postnatal developmental period from PND1 to week 3 then
showed a gradual decrease by an overall estimate of 2.5-fold by
week 51 (Sheu et al., 1990a). In the cortex and hippocampus,
quantification of GAP-43 protein was elevated during a period
of elevated synaptogenesis from PND14 to PND21 (Morita and
Miyata, 2013). Results from this study confirmed that GAP-43
is highly expressed in immature growing axonal terminals and
decreases during maturation with labeling showing an inverse
labeling pattern with synapsin and synaptotagmin (Morita and
Miyata, 2013).
During the aging process, GAP-43 levels show age-related
decrements. Both male and female aged rats exhibited less
GAP-43 mRNA in the hippocampus than younger counterparts
(Chao et al., 1992). In vitro phosphorylation of GAP-43 in the
hippocampus of 5-, 11- and 25-month old rats revealed a near
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50% reduction in the 25-month old rats when compared to
11-month old rats (Barnes et al., 1988). A decrease of GAP-43
immunoreactivity was also noted in the dentate gyrus, cingulate
cortex and olfactory bulb in 31-month-old Wistar rats compared
to 3- and 18-month olds (Casoli et al., 1996).
During development of the human brain, GAP-43 mRNA
expression shows a sharp decline from birth to 2 years of
age and levels-off until about 5 years of age (Webster et al.,
2011). In contrast, levels of GAP-43 protein appear to remain
similar across these ages (Webster et al., 2011). In Alzheimer’s
disease (AD), PKC-mediated phosphorylation of GAP-43 has
been shown to be decreased (Florez et al., 1991). End-stage AD
brains exhibited reduced neuronal expression of GAP-43 mRNA
with GAP-43 protein showing translocation to membranes of
swollen neurites (de la Monte et al., 1995). Downregulated and
ectopic GAP-43 gene expression were hypothesized to reveal
a signature molecular indicator that preceded and progressed
with synaptic degeneration and ensuing dementia in AD (de la
Monte et al., 1995). In AD cases with high phosphorylated tau
(tangle) density, GAP-43 mRNA expression was reduced fivefold
compared to AD brains with low tangle density (Coleman et al.,
1992). In addition, a decrease in GAP-43 mRNA was found
in neurons showing tangle formation compared to adjacent
neurons without tangles in the parahippocampal cortex of AD
patients (Callahan et al., 1994). These correlations are worthwhile
of further exploration to determine the nature of the relationship
of these observations (i.e., whether tangle formation reduces
GAP-43 expression, whether reduced GAP-43 causes tangle
formation or whether both are a product of some other upstream
change such as plaque formation).
GAP-43 AS A MODERATOR OF
NEUROPLASTICITY
Long-Term Potentiation
LTP represents a set of pre- and post-synaptic cellular responses
that beget synaptic plasticity and may function to facilitate
axonal outgrowth (Bourne et al., 2013) during development and
regenerative processes after injury. GAP-43 is phosphorylated
by a Ca2+-dependent PKC process that is critical for its
functional contributions to LTP and synaptic plasticity (Akers
and Routtenberg, 1985). In vitro GAP-43 phosphorylation
was selectively increased 5 min after the induction of LTP
and was specifically related to enhanced synaptic efficiency
(as measured by an increase in the spike amplitude after
high frequency stimulation compared to baseline) because
low frequency, nonpotentiating stimulation did not increase
(or decrease) GAP-43 phosphorylation (Routtenberg and
Lovinger, 1985). Three days following perforant path LTP
induction, dorsal hippocampus tissue showed augmented
GAP-43 phosphorylation which was greater than tissue from
control animals that received low frequency stimulation
(Lovinger et al., 1985). In vivo tetanic stimulation of the mossy
fiber pathway was associated with increased PKC-mediated
GAP-43 phosphorylation one and five but not 60 min after
stimulation indicative of a role for GAP-43 phosphorylation
in the induction but not maintenance of LTP within mossy
fiber synaptic membranes (Son et al., 1997). GAP-43 mRNA
expression in hilar cells was increased after a 48-h time lapse
following in vivo perforant path tetanus stimulation in the
intact mouse (Namgung et al., 1997). The authors suggested
that phosphorylation of GAP-43 in the axon terminals by PKC
would set off a retrograde signal back to the nucleus to initiate
transcription. Inhibition of PKC-induced phosphorylation of
GAP-43 with monoclonal antibodies prevented the induction
of LTP in CA1 pyramidal neurons in vitro (Fedorov et al.,
1995). Ten to 60 min, but not 90 min, following LTP
induction in the CA1 field of rat hippocampal slices, GAP-43
phosphorylation was increased (Ramakers et al., 1995) but
elevated phosphorylation was not seen if stimulation failed to
induce LTP (Ramakers et al., 1995, 1999). As well, one but not
2 h after LTP induction, GAP-43 and PKCγmRNAhybridization
were increased (Meberg et al., 1995) whereas 3 days after LTP
induction, GAP-43, PKCβ and PKCγ mRNA expression in the
CA3 subfield was decreased (Meberg et al., 1993). The authors
hypothesized that decreased expression 3 days after LTP might
be associated with a reduced growth potential leading to synaptic
stabilization in the activated pathways (Meberg et al., 1993).
Genetic overexpression of the constitutively phosphorylated
form of GAP-43 enhanced presynaptic paired-pulse facilitation
and LTP in the CA1 hippocampal region (Hulo et al., 2002);
an effect that was absent in transgenic mice overexpressing
the non-phosphorylatable form. The authors concluded that
the phosphorylation state of GAP-43 facilitated presynaptic
function affecting LTP and, ultimately, synaptic plasticity
(Hulo et al., 2002). As mentioned, presynaptic GAP-43
phosphorylation can be augmented in a PKC-dependent
manner by retrograde messengers liberated from postsynaptic
NMDA receptor activation (Luo and Vallano, 1995).
Application of AA at LTP-inducing concentrations significantly
increased translocation of PKC to the presynaptic membrane
in hippocampus with concomitant increased GAP-43
phosphorylation suggesting that AA contributes to LTP via
activation of presynaptic PKC-mediated phosphorylation of
GAP-43 (Luo and Vallano, 1995).
Memory Formation
Because LTP induction is associated with increased
phosphorylation of GAP-43, it is important to demonstrate
that similar changes in GAP-43 phosphorylation occur with
measures of behavioral memory. In this vein, heterozygous
knock-out of GAP-43 in mice resulted in a compromised
memory for a shock-paired environment (Rekart et al., 2005).
This was specific to a contextual memory as there were no
deficits in shock-conditioning to a tone cue and tests of
nociceptive and auditory function were intact (Rekart et al.,
2005). In a related study, phosphorylation of hippocampal
GAP-43 remained elevated for 1.5–72 h after acquisition of a
context-shock association (Young et al., 2002). Also noted in this
study was that 15–90 min after context-shock acquisition, PKCα
and PKCγ translocated to the membrane, while 15–30 min
after training, PKCβII and PKCe translocated to the cytosol
(Young et al., 2002) possibly reflecting an mRNA regulation
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mechanism. PKCβII and PKCε then were seen in the membrane
fraction at later time points suggesting a translocation back to
the membrane coincident with the GAP-43 phosphorylation
time course leading the authors to conclude that these two PKC
isoforms were responsible for the phosphorylation of GAP-43.
Two studies reported on the phosphorylation state of GAP-43
and its effect on behavioral memory. Three lines of transgenic
mice were developed (Aigner et al., 1995), each possessing an
alteration of the PKC phosphorylation site on the GAP-43
amino acid sequence: (1) G-Phos mice overexpressed the native
form (phosphorylatable and dephosphorylatable; no mutation)
of chicken GAP-43; (2) G-Perm mice overexpressed chicken
GAP-43 that was permanently, pseudophosphorylated with an
aspartate substitution for serine at position 42; (3) the GNonP
mice overexpressed a nonphosphorylatable form of chicken
GAP-43 in which alanine was substituted at the serine-42
site. Assessment of behavioral memory function in each of
these transgenic lines revealed the following: (1) G-Phos mice
showed improved spatial memory function on a water maze task;
(2) G-Perm mice showed a deficit in their ability to extinguish
a classically-conditioned context-shock association indicative of
a memory persistence; (3) G-NonP mice showed a significant
impairment in their ability to recall spatial information on the
water maze task (Holahan and Routtenberg, 2008). G-Phos mice
were further subdivided based on their water maze acquisition
rates and hippocampal GAP-43 levels into ‘‘spatial bright’’ and
‘‘spatial dull’’ groups. The ‘‘spatial dull’’ group showed impaired
acquisition and retention on the spatial version of the water maze
task but performed similar to controls on the visible platform
task. The ‘‘spatial bright’’ group showed enhanced memory
function compared to controls on a nonmatching to place water
maze task (hidden platform moved every day). Interestingly, the
‘‘dull’’ group was found to have 50% more transgenic GAP-43
protein and a two-fold increase in transgenic GAP-43 mRNA in
the hippocampus compared to the ‘‘bright’’ group (Holahan et al.,
2007). These results indicated that elevated concentrations of the
transgenic GAP-43 molecule impaired memory formation and
subsequent studies (Rekart and Routtenberg, 2010) showed large
aggregates in these mice reminiscent of protein aggregation as
seen in neurodegenerative diseases (Jucker and Walker, 2013).
Two other studies examined the relationship between altered
GAP-43 labeling and presynaptic remodeling after memory
formation. Rats in the first study were given a spatial memory
retention test 1 or 30-days after initial training. The 30-day group
showed elevated GAP-43 staining in the anterior cingulate cortex
compared to the 1-day retention group (Maviel et al., 2004).
In the second study, high-resolution MRI analysis revealed a
structural remodeling in the hippocampus of mice trained on
the spatial version of a water maze task with correlated increased
GAP-43 staining (Lerch et al., 2011).
Critical or Supporting Factor in Plasticity?
An increase in presynaptic glutamate release has been shown
to be associated with the observation of LTP (Lynch et al.,
1990; Richter-Levin et al., 1995). Quantal analysis of failure
rates before and after LTP induction in the hippocampus has
revealed that enhanced synaptic efficacy is partially dependent
on an increase in the probability of transmitter release (Bekkers
and Stevens, 1990; Malinow and Tsien, 1990; Stevens and
Wang, 1994). The influx of Ca2+ and binding to particular
proteins involved in vesicular exo- and endocytosis mediates
the transport and docking of glutamatergic vesicles facilitating
vesicle recycling and release machinery. Because phosphorylated
GAP-43 shows interactions with a number of synaptic vesicle
proteins (Haruta et al., 1997), it may bridge the gap between those
proteins involved in endocytosis and those involved in exocytosis
(Rizo and Südhof, 2002; Sudhof, 2004; Jahn and Scheller,
2006; Sudhof and Rothman, 2009) thereby facilitating glutamate
(or other neurotransmitters) vesicular recycling during times
of plasticity including development, learning or regeneration.
As a coordinator of axonal function, phosphorylation of
GAP-43 would promote actin filaments not only for axonal
rearrangement but also the coordinated release and recycling
of transmitter vesicles (see Denny, 2006). In its contribution
to vesicle recycling, phosphorylated GAP-43 would activate
heterotrimeric G proteins translocating the protein to the
presynaptic membrane and potentially leading to a change in
membrane tension facilitating vesicular recycling (Denny, 2006).
In addition to these actions, GAP-43 phosphorylation dissociates
GAP-43 from CaM which would then interact with vesicular
proteins. Phosphorylated GAP-43 by PKC would provide a
sustained mechanism for vesicular recycling and release CaM
to further enhance vesicular recycling leading to enhanced
glutamate release, potentiation of cellular plasticity and enhanced
memory function. In these cases, it appears that GAP-43 supports
the activity of a number of proteins and kinases that are critical
for presynaptic function.
GAP-43 AS A MEDIATOR OF AXONAL
OUTGROWTH
Injury-Induced Regeneration and
Associated Changes in GAP-43
Following axon damage, GAP-43 translation is up-regulated in
close temporal sequence with nerve regeneration, potentially
mimicking an early developmental phase (Benowitz and
Routtenberg, 1997). As an example, a reduction in GAP-43
protein levels is noted in motor nerves and neuromuscular
junctions during the second postnatal week. However, it
is upregulated in these tissues during the injury-induced
regeneration process and in mice overexpressing transgenic,
native (phosphorylatable) GAP-43, nerve sprouting in these
tissues is potentiated (Caroni, 1997). Likewise, overexpression of
GAP-43 was reported to promote Purkinje axon plasticity and
an enhanced regenerative potential even though, in the control
condition, these neurons show poor regenerative potential (Rossi
et al., 2001; Gianola and Rossi, 2004, 2005). Following laser
axotomy of adult climbing fiber axonal branches, new branches
with varicosities and a large numbers of vesicles were observed
to sprout in close proximity to the intact surrounding Purkinje
dendrites (Allegra Mascaro et al., 2013). Downregulation of
GAP-43 mRNA activity via an interference approach resulted in
a significant increase in the turnover of presynaptic boutons and
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impeded the appearance of reactive sprouts suggesting a critical
role for GAP-43 in initiating and sustaining axonal regrowth after
injury (Allegra Mascaro et al., 2013).
Three days after in vivo damage to the sciatic nerve in
adult rats, GAP-43 staining begins to appear in the axotomized
DRG cells with subsequent transport into the newly formed
sprouts (Gispen et al., 1990; Woolf et al., 1990). GAP-43 staining
intensity was observed to peak 21 days after damage and was
absent 9 weeks following sciatic nerve crush injury and 36 weeks
following nerve cut (Woolf et al., 1990). By using an RNA
interference approach, GAP-43 downregulation resulted in a
significant decrease in newly formed branches in climbing fibers
following axotomy (Allegra Mascaro et al., 2013). In this report,
GAP-43 mRNA downregulation also attenuated the appearance
of newly formed sprouts indicating a causal link between GAP-43
and the initiation of axonal regrowth after injury (Allegra
Mascaro et al., 2013). After spinal cord injury, administration of
IL-6 was shown to enhance neurite outgrowth that was associated
with an increased expression of GAP-43 mRNA indicating that
IL-6 may be a factor that can initiate a GAP-43 associated growth
outcome to promote axonal regrowth and functional recovery
(Yang et al., 2012). In these instances, GAP-43 appears to play
a critical role in axonal outgrowth.
Following deafferentation of the olfactory epithelium or
after olfactory bulbectomy, levels of GAP-43 mRNA and
protein increase in conjunction with the formation of immature
olfactory sensory neurons (Verhaagen et al., 1990). Three
weeks after binocular retinal lesions (central 10 degrees) in
adult cats, GAP-43 staining was elevated in the dorsal lateral
geniculate nucleus region that represents this retinal area
(Baekelandt et al., 1994). Elevated GAP-43 staining was also
found in catecholaminergic and serotonergic axonal sprouts that
regenerate around the damaged area associated with axotomy
of the medial forebrain bundle (Alonso et al., 1995). Cochlear
neuron removal in adult rats results in elevated GAP-43
protein staining in the fibers of the ipsilateral ventral cochlear
nucleus and somas of the lateral superior olive (Illing and
Horvath, 1995). After unilateral cochlear ablation, GAP-43
expression was tightly linked with the accumulation of matrix
metalloprotease-2 (MMP-2), a major actor in extracellular
matrix remodeling suggesting that MMP-2 may provide a signal
for GAP-43-directed axonal outgrowth and synaptogenesis
following damage (Fredrich and Illing, 2010). Five to 7 days
after experimental tooth movement, axonal terminals of the
periodontal Ruffini endings showed elevated GAP-43 staining
with a complete disappearance 14 days later suggesting that
GAP-43 may function as a key molecule in the remodeling of
mechanoreceptive endings during tooth movement (Kobayashi
et al., 1998).
In an animal model of middle cerebral artery occlusion
(MCAo), behavioral recovery as assessed with a pellet-reaching
task occurred during a 14-day period after MCAo and in the
affected cervical gray matter, GAP-43 staining on corticospinal
tract axons was significantly increased during the same period
while synaptophysin increased in axonal terminals at 28 days (Liu
et al., 2013). In another stroke model, optogenetic stimulation in
the primary motor cortex on the same side of the damage was
shown to facilitate motor recovery and increase the expression
of multiple neurotrophins such as brain-derived neurotrophic
factor (BDNF), NGF as well as increase in the expression of
GAP-43 (Cheng et al., 2014).
GAP-43 immunoreactivity in layer IV of the barrel cortex
receptor field are moderate in the inter-barrel septa and low
within the barrels themselves in the adult rat (Dunn-Meynell
et al., 1992). The distribution of GAP-43 was then examined
1–8 weeks after unilateral vibrissectomy of all but the C3 vibrissa
to assess the outcome and time course on GAP-43 distribution
in the barrel cortex. Following vibrissectomy, the GAP-43
immunonegative C3 area showed a reduction in volume from
8.4% at 1 week after injury to a 12% decrease 8 weeks after
damage relative to the control ipsilateral cortex suggesting a
GAP-43-mediated axonal sprouting within the barrel cortex
whereby GAP-43 positive terminals encroached on areas that
lacked GAP-43 (Dunn-Meynell et al., 1992). In a second study
utilizing a similar injury model (unilateral vibrissectomy sparing
the C3 vibrissa), GAP-43 levels were elevated 25% compared to
the unlesioned side for 6 days following surgery then decreased
by 88% at 7 days and returned to baseline by 14 days (Levin and
Dunn-Meynell, 1993).
Lesions of the hippocampal perforant path are associated
with an elevated distribution of GAP-43 protein during the
phase of synaptogenesis (Neve et al., 1991). Following unilateral
entorhinal cortex (EC) lesions in adult rats, a 2-fold (100%)
increase of recently synthesized GAP-43 was noted in the
contralateral hippocampus where sprouting occurred. This surge
in GAP-43 mobilization happened from 6 to 15 days after the
lesion and coincided with the growth of presynaptic terminals
(Lin et al., 1992).
In post-mortem AD brains, GAP-43 labeling indicated
presynaptic neurite outgrowth in the hippocampal molecular
layer, stratum polymorphous, the CA1 and prosubiculum with
a high number of GAP-43-immunoreactive coiled fibers and
dystrophic neurites closely apposed to plaques (Masliah et al.,
1991). A reliable increase in GAP-43 staining in the stratum
lacunosum moleculare subfield of the hippocampus was also
observed in AD patients compared to age-matched controls and
was positively correlated with the severity of AD (Rekart et al.,
2004). This hippocampal subfield contains inputs from the EC so
the authors surmised that increased GAP-43 expression reflected
aberrant neuronal sprouting and this, in conjunction with
neurodegeneration, could culminate in memory dysfunction
associated with AD (Rekart et al., 2004).
In addition to physical structural damage resulting in elevated
GAP-43 levels and axonal sprouting, excitotoxicity has been
shown to increase GAP-43-dependent sprouting (Gravel et al.,
2011). In one such study (Cantallops and Routtenberg, 1996),
12 h after subcutaneous administration of the excitatory agonist
kainate, GAP-43 mRNA expression increased in granule cells
and 2 days after kainate injection (up to 40 days), GAP-43
protein levels and mossy fiber sprouting into the supragranular
layer of the hippocampus were observed. These outcomes are
similar to those seen after structural or neuronal damage
which result in axonal outgrowth with one difference that
kainate treatment did not result in substantial physical cell loss
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(Cantallops and Routtenberg, 1996). The sum total of these
studies suggests that elevations in either GAP-43 mRNA or
protein levels or, enhanced phosphorylation status of GAP-43
lead to elevated axonal structural remodeling thereby revealing
a critical role for this growth-associated factor.
GAP-43 Stabilization as a Critical Factor in
Axonal Outgrowth
Because HuD protein serves to stabilize GAP-43 mRNA, it
may be one target to enhance GAP-43 activity and hence,
promote axonal outgrowth. Overexpression of HuD protein
in PC12 cells stabilized GAP-43 mRNA by attenuating the
onset of mRNA degradation (Beckel-Mitchener et al., 2002)
and morphological analysis revealed multiple GAP-43-positive
neurites that contained tubulin and F-actin that occurred in
the absence of NGF with overexpression of full length but not
truncated HuD (Anderson et al., 2000). With truncated HuD,
GAP-43 mRNA was not stabilized and these cells showed no
spontaneous outgrowth and a lack of growth in the presence
of NGF (Anderson et al., 2000). While in normal cortical
neurons, in vitro neurite outgrowth occurs over a 3-day period
with associated elevations in GAP-43 and HuD expression;
overexpression of HuD can accelerate the formation of neurite
outgrowth, increase the number of GAP-43 positive cells that
undergo differentiation and result in a twofold increase in
GAP-43 mRNA (Anderson et al., 2001). These results point to
a central role for HuD regulation of GAP-43 expression during
the initial stages of neurite outgrowth (Anderson et al., 2001)
and may therefore be a target for jump-starting a therapeutic
process in regeneration after injury. In this regard, the levels and
expression of HuD and GAP-43 mRNA in DRG neurons were
examined following sciatic nerve injury (Anderson et al., 2003).
Seven days following injury, HuD and GAP-43 mRNA in the
ipsilateral DRG increased by two- and six-fold relative to the
contralateral DRG (Anderson et al., 2003). That GAP-43 stability
may be the pivotal factor in facilitated neurite outgrowth comes
from evidence that overexpression of full length KH-type splicing
regulatory protein (KSRP), which promotes the deterioration
of GAP-43 mRNA, hindered axonal outgrowth in hippocampal
cultures while depletion of KSRP led to a rise in GAP-43 mRNA
levels and a significant increase in axonal length (Bird et al.,
2013). Overexpression of GAP-43 was shown to reverse the
axonal outgrowth inhibition seen with KSRP overexpression,
but only when the cells were transfected with GAP-43 that
was targeted for transport to the axons (Bird et al., 2013).
These results point to KSRP as a central regulator of GAP-43
mRNA stability and axonal malleability that works in contrast
to HuD in the regulation of GAP-43 neuronal mRNAs (Bird
et al., 2013). Therefore, enhancing the stability of GAP-43
mRNA via mRNA binding proteins, such as HuD, may facilitate
intracellular protein-protein interactions culminating in the
appropriate intracellular environment for axonal elongation (van
Kesteren et al., 2011).
Targeting the Inhibitors of GAP-43
Another potential, indirect mechanism for elevating GAP-43
expression and facilitating neurite outgrowth is via inhibition
of Nogo-A-dependent processes. Nogo-A is a myelin-derived
inhibitor that plays a central role in the prevention of axonal
outgrowth (Chen et al., 2000; Pot et al., 2002). Axons within
the central nervous system show poor potential to recover after
an insult due to the actions of myelin-derived inhibitors of
axonal outgrowth such as Nogo, myelin-associated glycoprotein
(MAG) and oligodendrocyte-myelin glycoprotein (OMgp), all
of which show affinity and bind to the Nogo-66 receptor (for
reviews, see Huber and Schwab, 2000; Reilly, 2000; Fournier
et al., 2002; Pernet and Schwab, 2012; Schwab and Strittmatter,
2014). In order for GAP-43 to be effective in coordinating axonal
regeneration, it might be necessary to inhibit the action of Nogo
or other inhibitors of axonal growth.
In two studies examining axonal repair after traumatic
brain injury (TBI), inhibiting Nogo-A expression with an anti-
Nogo-A monoclonal antibody (Marklund et al., 2007) or with
exercise (Chytrova et al., 2008) resulted in an upregulation of
GAP-43 as well as improved functional outcomes during the
regenerative period. Following damage in the rat corticospinal
tract, application of the anti-Nogo-A monoclonal antibody
was associated with upregulation of GAP-43 and triggered
regenerative sprouting across the midline with appropriate
sensory and motor fiber innervation that was stable and
persistent (Bareyre et al., 2002). Axonal regrowth emanating
from retinal ganglion cells after optic nerve damaged was
investigated in both Nogo-A knockout mice (Su et al., 2008)
and Nogo-66 receptor knockout mice (Su et al., 2009). In both
cases, GAP-43 expression was significantly higher during the
regeneration period and axonal growth was significantly greater
than the wild type condition. In primary retinal ganglion cells,
Nogo-A RNA inhibition or a peptide antagonist of the Nogo-66
functional domain promoted axonal outgrowth as assessed using
GAP-43 immunofluorescence (Huo et al., 2013) suggesting
a close relationship between GAP-43 and neurite extension
induced by inhibition of Nogo-A function. In rats with spinal
cord hemisection, adenovirus-mediated transfection of Nogo-A
short hairpin RNAs were found to reduce the expression of
the Nogo-A gene and upregulate GAP-43 expression with an
associated functional recovery of the injured nerves (Liu et al.,
2016). Therefore, impeding Nogo gene expression may be an
important step leading to the upregulation of GAP-43 in the
promotion of spinal cord axonal outgrowth. In this case, Nogo
would be the critical factor in axonal outgrowth and GAP-43
would support this function.
Systemic administration of small interfering RNA-Nogo-A in
a mouse model of experimental autoimmune encephalomyelitis
was shown to enhance GAP-43 positive axons in the lesioned
area and promote axonal repair (Yang et al., 2010). Four
weeks after TBI, scores on a hippocampal-dependent novel
object recognition test were increased in Nogo-66 knockout
mice compared to wild-type along with elevated GAP-43
protein staining in the injured and contralateral sides of the
hippocampus (Tong et al., 2013). In a similar TBI model,
progesterone administration was shown to significantly decrease
the expression of Nogo-A and upregulate GAP-43 protein
suggesting that progesterone may promote neuroprotection by
inhibiting Nogo-A and increasing GAP-43 (Liu et al., 2014).
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Constraint-induced movement therapy after focal cerebral
ischemia in rats was reported to significantly increase the
length and number of midline crossings of corticospinal
axons, decreased the expression of Nogo-A/Nogo receptor
and increase the expression of GAP-43 in the denervated
spinal cord all associated with improved motor function (Zhao
et al., 2013). Therefore, the synergistic effect of reducing
Nogo-A-inhibitory processes and upregulating intracellular
GAP-43 growth permissive processes may provide the optimal
environment for axonal regeneration. In this scenario, GAP-43
would be the supporting factor mediating a critical step
between extracellular signals and intercellular membrane
dynamics.
CONCLUDING REMARKS
The historical and current work investigating the role of
GAP-43 in nervous system function has revealed that its mRNA
expression or protein levels increase in conjunction with
axonal structural plasticity as occur during development and
maturation, with input-dependent memory related processes
and following axonal injury during the regeneration phase.
Because all of these events can culminate in reorganization
of presynaptic elements (i.e., axons), the transcriptional
and post-transcriptional regulation of the mRNA and the
post-translational modification (phosphorylation) and protein
localization were intensely scrutinized as a means to facilitate
central nervous system plasticity. Many growth permissive
events in the central nervous system are associated with
the augmentation of GAP-43 levels suggesting it may have
been a critical factor for plasticity-associated axonal function.
While upregulation of GAP-43 protein phosphorylation
status, enhanced stability of GAP-43 mRNA and inhibition of
Nogo-A/Nogo66 inhibitory processes have all been shown to
promote axonal outgrowth, GAP-43 appears to play a more
permissive role in axonal plasticity being an important node in
coordinating various other critical factors. If nothing else, the
exploration of GAP-43 function and upstream and downstream
regulators has stimulated the search for targeted therapeutics
directed to facilitate CNS regeneration after axonal injury
(see Ribas and Costa, 2017) and possibly, developmental
disorders, memory dysfunction and neurodegenerative
diseases.
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